Skip to main content
. 2007 Sep 11;97(6):778–784. doi: 10.1038/sj.bjc.6603949

Figure 1.

Figure 1

Kaplan–Meier probability of progression-free survival (A) and overall survival (B) with respect to the EGFR mutation status of NSCLC. P-values were calculated by the log-rank test.